ZUG, Switzerland and BOSTON, March 26, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options become available today, for the April 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

These files are composed of master and return components, available separately or combined. CRSP stock files are further differentiated by the frequency at which prices and returns are reported, daily ...

In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other shorted stocks in 2025. Reuters reported that President Trump’s tariffs have ...

NasdaqGM:CRSP Earnings Per Share Growth as at Mar ... Despite some promising product announcements, such as the FDA's RMAT designation for CTX112, these developments have not compensated for ...